SLB vs TCRX · P/E 12, rev $8.97B vs rev $2.0M
Schlumberger NV (SLB) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Schlumberger NV (SLB) is a oil & gas equipment & services company listed on US. It is led by Olivier Le Peuch.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported SLB revenue for 2026-06-30 was $8.97B. Net income was $786.0M. Revenue was up 2.9% from 2026-03-31 to 2026-06-30. SLB currently screens at market cap $48.16B and trailing P/E 12.1.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
SLB currently screens at market cap $48.16B and trailing P/E 12.1. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the SLB and TCRX stock pages for the full models.
Not investment advice.